Abstract
To investigate the relationship between apoptosis and histologic types in invasive squamous cell carcinoma and adenocarcinoma of the uterine cervix. The present study involved the assessment of surgical specimens from 74 women with cervical carcinomas FIGO stage IB1 (54 squamous cell carcinomas and 20 adenocarcinomas). The study samples were obtained from selected paraffin blocks containing specimens from patients submitted to surgical procedures. The respective medical charts of patients were reviewed and epidemiologic, clinical and disease-related data were collected. Cervical specimens were assessed by the immunohistochemistry technique using the Bcl-2 protein as a marker. The reactions were considered positive when the cells became stained in brown color. Bcl-2 positive cells were counted in 10 fields under a high magnification (400x) using light microscopy, in the slides area containing squamous carcinoma and adenocarcinoma of the cervix. The total cell count was expressed as the number of positive Bcl-2 cells per mm2. No significant difference in the number of cells marked by the Bcl-2 protein was found for the variables age, tumor diameter, angiolymphatic invasion or number of lymph nodes affected. Comparison of the number of cells marked by the Bcl-2 protein in the two histological groups revealed a statistically significant difference, with squamous tumors presenting a greater number of marked cells. Squamous cervical tumors present a greater number of positive Bcl-2 cells per mm2, suggesting that that the rate of cell death in squamous cell carcinomas of the cervix is lower than in adenocarcinomas.
Similar content being viewed by others
References
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108
Maucort-Boulch D, Franceschi S, Plummer M, IARC HPV Prevalence Surveys Study Group (2008) International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev 17(3):717–720
World Health Organization (2008) WHO. World Cancer Report, 2008. International Agency for Research on Cancer, Lyon
Smith HO, Tiffany MF, Qualis CR, Key CR (2000) The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States- a 24-year population-based study. Gynecol Oncol 78(2):97–105
Tjalma WA, Van Waes TR, Van den Eeden LEM, Bogers JJPM (2005) Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 19(4):469–483
Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G, Vlastos AT (2007) Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 7:164
Mathew A, George PS (2009) Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix–worldwide. Asian Pac J Cancer Prev 10(4):645–650
Berrington de González A, Green J (2007) Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 120(11):2525
Bosch FX, de Sanjosé S (2007) The epidemiology of human papillomavirus infection and cervical câncer. Dis Markers 23(4):213–227
Fregnani JH, Soares FA, Novik PR, Lopes A, Latorre MR (2008) Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 136(2):215–223
Hopkins MP, Morley GW (1991) A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 77:912–917
Shingleton HM, Bell MC, Fremgen A et al (1995) Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 76(10 Suppl):1948–1955
Eifel PJ, Burke TW, Morris M, Smith TL (1995) Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 59:38–44
Look KY, Brunetto VL, Clarke-Pearson DL et al (1996) An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 63:304–311
Ayhan A, Al RA, Baykal C, Demirtas E, Yuce K, Ayhan A (2004) A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma. Int J Gynecol Cancer 14:279–285
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495–516
Fulda S, Gorman AM, Hori O, Samali A (2010) Cellular stress responses: cell survival and cell death. Int J Cell Biol 2010:214074
FIGO (2009) Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 105:103–104
Campaner AB, Longo Galvão MA (2009) Application of an easy and useful morphometric technique for immunohistochemistry counting. Gynecol Oncol 112(1):282–283
D’Amelio M, Tino E, Cecconi F (2008) The apoptosome: emerging and new potential targets for drug design. Pharm Res 25:740–751
Okun I, Balakin KV, Tkachenko SE, Ivachtchenko AV (2008) Caspase activity modulators as anticancer agents. Anticancer Agents Med Chem 8(3):322–341
Gewies A (2003) Introduction of apoptosis. ApoReview. [serial online] 1–26. Available from: http://www.celldeath.de/encyclo/aporev/aporev.htm [2006 June 7]
Kang MH, Reynolds CP (2009) Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15(4):1126–1132
Tjalma WA, Weyler JJ, Bogers JJ, Pollefliet C, Baay M, Goovaerts GC, Vermorken JB, van Dam PA, van Marck EA, Buytaert PM (2001) The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 97(2):223–230
Borner C (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39(11):615–647
Kallel-Bayoudh I, Hassen HB, Khabir A, Boujelbene N, Daoud J, Frikha M, Sallemi-Boudawara T, Aifa S, Rebaï A (2010) Bcl-2 expression and triple negative profile in breast carcinoma. Med Oncol. [epub ahead of print]
Kokawa K, Shikone T, Otani T, Nakano R (1999) Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Cancer 85(8):1799–1809
Dimitrakakis C, Kymionis G, Diakomanolis E, Papaspyrou I, Rodolakis A, Arzimanoglou I, Leandros E, Michalas S (2000) The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol Oncol 77(1):129–136
Yao JF, Zhou CY, Wei LF, Wang SY, Shi YF (2008) Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations. Zhonghua Fu Chan Ke Za Zhi 43(3):205–208
Stergiou L, Hengartner MO (2004) Death and more: DNA damage response pathways in the nematode C. elegans. Cell Death Differ 11(1):21–28
Conflict of Interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eduardo, M.G.D.P., Campaner, A.B. & Silva, M.A.L.G. Apoptosis Phenomena in Squamous Cell Carcinomas and Adenocarcinomas of the Uterine Cervix. Pathol. Oncol. Res. 21, 887–892 (2015). https://doi.org/10.1007/s12253-015-9906-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-015-9906-y